DE69535976D1 - Heilung von Wunden oder fibrotischen Krankheiten unter Verwendung von wenigstens einem Agens gegen einen Wachstumsfaktor - Google Patents

Heilung von Wunden oder fibrotischen Krankheiten unter Verwendung von wenigstens einem Agens gegen einen Wachstumsfaktor

Info

Publication number
DE69535976D1
DE69535976D1 DE69535976T DE69535976T DE69535976D1 DE 69535976 D1 DE69535976 D1 DE 69535976D1 DE 69535976 T DE69535976 T DE 69535976T DE 69535976 T DE69535976 T DE 69535976T DE 69535976 D1 DE69535976 D1 DE 69535976D1
Authority
DE
Germany
Prior art keywords
growth factor
wounds
healing
fibrotic diseases
agent against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69535976T
Other languages
English (en)
Inventor
Mark William James Ferguson
Shah Mamta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9406154A external-priority patent/GB2288118A/en
Priority claimed from GBGB9424898.6A external-priority patent/GB9424898D0/en
Application filed by Renovo Ltd filed Critical Renovo Ltd
Application granted granted Critical
Publication of DE69535976D1 publication Critical patent/DE69535976D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
DE69535976T 1994-03-29 1995-03-29 Heilung von Wunden oder fibrotischen Krankheiten unter Verwendung von wenigstens einem Agens gegen einen Wachstumsfaktor Expired - Lifetime DE69535976D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9406154A GB2288118A (en) 1994-03-29 1994-03-29 Wound healing composition
GBGB9424898.6A GB9424898D0 (en) 1994-12-09 1994-12-09 Wound healing

Publications (1)

Publication Number Publication Date
DE69535976D1 true DE69535976D1 (de) 2009-08-13

Family

ID=26304595

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69535976T Expired - Lifetime DE69535976D1 (de) 1994-03-29 1995-03-29 Heilung von Wunden oder fibrotischen Krankheiten unter Verwendung von wenigstens einem Agens gegen einen Wachstumsfaktor
DE69513158T Expired - Lifetime DE69513158T2 (de) 1994-03-29 1995-03-29 Wundheilung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69513158T Expired - Lifetime DE69513158T2 (de) 1994-03-29 1995-03-29 Wundheilung

Country Status (12)

Country Link
US (1) US5972335A (de)
EP (2) EP0754058B1 (de)
JP (1) JP4083794B2 (de)
AT (2) ATE435030T1 (de)
AU (1) AU710153B2 (de)
CA (1) CA2186269C (de)
DE (2) DE69535976D1 (de)
DK (2) DK0754058T3 (de)
ES (2) ES2329531T3 (de)
GR (1) GR3032266T3 (de)
NZ (1) NZ282856A (de)
WO (1) WO1995026203A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
GB9601081D0 (en) * 1995-10-06 1996-03-20 Cambridge Antibody Tech Specific binding members for human transforming growth factor beta;materials and methods
GB2306481A (en) 1995-10-21 1997-05-07 Univ Manchester Pharmaceutical comprising a stimulator of activin and/or inhibin
GB9702943D0 (en) 1997-02-13 1997-04-02 Univ Manchester Wound healing
DE10022074A1 (de) * 2000-05-06 2001-11-08 Henkel Kgaa Elektrochemisch erzeugte Schichten zum Korrosionsschutz oder als Haftgrund
US6509318B1 (en) * 2000-09-29 2003-01-21 The Regents Of The University Of California TGF-B inhibitors and methods
US7569132B2 (en) * 2001-10-02 2009-08-04 Henkel Kgaa Process for anodically coating an aluminum substrate with ceramic oxides prior to polytetrafluoroethylene or silicone coating
US7452454B2 (en) * 2001-10-02 2008-11-18 Henkel Kgaa Anodized coating over aluminum and aluminum alloy coated substrates
GB0217136D0 (en) * 2002-07-24 2002-09-04 Renovo Ltd Wound healing & treatment of fibrosis
US20050074453A1 (en) * 2003-10-02 2005-04-07 Ferree Bret A. Methods of preventing adhesions following laminectomies and other surgical procedures
CN1961003B (zh) * 2004-03-31 2013-03-27 健泰科生物技术公司 人源化抗TGF-β抗体
EP2498798A4 (de) * 2009-11-10 2014-01-01 Univ Columbia Zusammensetzungen und verfahren zur wundbehandlung
US10434213B2 (en) * 2010-03-05 2019-10-08 Wake Forest University Health Sciences Controlled delivery system
EP2744820B1 (de) 2011-08-17 2018-07-25 Keranetics LLC Verfahren zur extraktion von keratinischen proteinen
WO2013025941A1 (en) 2011-08-17 2013-02-21 Keranetics Llc Low protein percentage gelling compositions
SG10201704616SA (en) * 2012-11-06 2017-07-28 Scholar Rock Inc Compositions and methods for modulating cell signaling
US9827245B2 (en) 2013-03-15 2017-11-28 KeraNetics, LLC Keratin compositions comprising halofuginone
AU2014262843B2 (en) 2013-05-06 2017-06-22 Scholar Rock, Inc. Compositions and methods for growth factor modulation
AU2017268234A1 (en) 2016-05-17 2018-12-13 Genentech, Inc. Stromal gene signatures for diagnosis and use in immunotherapy
EP3707510B1 (de) 2017-11-06 2024-06-26 F. Hoffmann-La Roche AG Diagnose- und therapieverfahren für krebs
WO2023080900A1 (en) 2021-11-05 2023-05-11 Genentech, Inc. Methods and compositions for classifying and treating kidney cancer
WO2024077095A1 (en) 2022-10-05 2024-04-11 Genentech, Inc. Methods and compositions for classifying and treating bladder cancer
WO2024077166A1 (en) 2022-10-05 2024-04-11 Genentech, Inc. Methods and compositions for classifying and treating lung cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624789B2 (en) * 1987-02-19 1992-06-25 Amgen, Inc. Purified platelet-derived growth factor and methods for purification thereof
US5094941A (en) * 1987-12-31 1992-03-10 Zymogenetics, Inc. Monoclonal antibodies to PDGF
EP0775742A3 (de) * 1989-09-29 1998-01-14 La Jolla Cancer Research Foundation Inhibierung von TGF-beta zur Verhinderung von extrazellulärer Matrixanhäufung
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
WO1993010808A1 (en) * 1991-12-04 1993-06-10 La Jolla Cancer Research Foundation INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
AU3943793A (en) * 1992-04-01 1993-11-08 Whittier Institute For Diabetes And Endocrinology, The Methods of inhibiting or enhancing scar formation in the CNS
GB9217206D0 (en) 1992-08-13 1992-09-23 Pointer John C Photo labels
AU5587094A (en) * 1992-10-26 1994-05-24 Kirin Brewery Company, Limited Method for producing large latent transforming growth factor-beta complexes and large latency associated peptide
JP4350370B2 (ja) * 2002-12-27 2009-10-21 株式会社半導体エネルギー研究所 電子回路及び電子機器

Also Published As

Publication number Publication date
AU710153B2 (en) 1999-09-16
NZ282856A (en) 1998-06-26
ES2140670T3 (es) 2000-03-01
EP0968723B1 (de) 2009-07-01
AU2077895A (en) 1995-10-17
JP4083794B2 (ja) 2008-04-30
EP0754058B1 (de) 1999-11-03
US5972335A (en) 1999-10-26
ATE186220T1 (de) 1999-11-15
ES2329531T3 (es) 2009-11-26
JPH09510967A (ja) 1997-11-04
EP0754058A1 (de) 1997-01-22
CA2186269A1 (en) 1995-10-05
EP0968723A1 (de) 2000-01-05
CA2186269C (en) 2008-06-03
ATE435030T1 (de) 2009-07-15
WO1995026203A1 (en) 1995-10-05
DE69513158T2 (de) 2000-05-04
DE69513158D1 (de) 1999-12-09
DK0754058T3 (da) 2000-02-07
GR3032266T3 (en) 2000-04-27
DK0968723T3 (da) 2009-11-09

Similar Documents

Publication Publication Date Title
ATE435030T1 (de) Heilung von wunden oder fibrotischen krankheiten unter verwendung von wenigstens einem agens gegen einen wachstumsfaktor
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
ATE196604T1 (de) Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und - regenerierung
DE69627467D1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
CY1111536T1 (el) Μεθοδοι και συνθεσεις για την καταστολη της διαφοροποιησης ινοκυτταρων
DE69902234D1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
EP0506658A4 (en) Compositions and method for treating painful, inflammatory or allergic disorders
DK1077941T3 (da) Forbindelser med væksthormonfrigörende egenskaber
ATE103815T1 (de) Verwendung von thrombospondin zur beschleunigung der wundheilung.
DE69131964D1 (de) Therapeutisches agens zur wundbehandlung
ES2195000T3 (es) Composicion farmaceutica.
ES2175006T3 (es) N-(pirimidinil)-benzosulfonamidas como medicamentos.
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
ATE345809T1 (de) Arzneimittelzusammensetzung enthaltend tcf-ii
DE69623316T2 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
ATE193450T1 (de) Pharmazeutische zusammensetzung zur vorbeugung oder behandlung von knochenbrüchen
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
BR9500886A (pt) Composições com efeito regulador de crescimento e método para o tratamento de culturas
RU96118184A (ru) Способ лечения рефлекторных синдромов при остеохондрозе

Legal Events

Date Code Title Description
8364 No opposition during term of opposition